66 related articles for article (PubMed ID: 37017821)
1. The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.
Wang Y; Zhu Y; Fan L; Liu J; Pan J; Xue W
Int Urol Nephrol; 2023 Jun; 55(6):1447-1452. PubMed ID: 37017821
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
Shee K; Cowan JE; Washington SL; Shinohara K; Nguyen HG; Cooperberg MR; Carroll PR
Eur Urol Oncol; 2023 Dec; ():. PubMed ID: 38057193
[TBL] [Abstract][Full Text] [Related]
3. Outcome of surgery in locally advanced pT3a prostate cancer.
Milonas D; Baltrimavicius R; Grybas A; Gudinaviciene I; Trumbeckas D; Kincius M; Auskalnis S; Jievaltas M
Cent European J Urol; 2011; 64(4):209-12. PubMed ID: 24578895
[TBL] [Abstract][Full Text] [Related]
4. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626
[TBL] [Abstract][Full Text] [Related]
5. The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors.
Porcaro AB; Orlando R; Panunzio A; Tafuri A; Baielli A; Artoni F; Montanaro F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Veccia A; Boldini M; Treccani LP; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Cerruto MA; Antonelli A
J Robot Surg; 2024 Mar; 18(1):134. PubMed ID: 38520651
[TBL] [Abstract][Full Text] [Related]
6. Does the Gleason Score 7 Upgrading Always Predict Worse Prognosis?
Zhou J; Yu M; Ding J; Qi J
Clin Genitourin Cancer; 2023 Dec; 21(6):e412-e421. PubMed ID: 37248147
[TBL] [Abstract][Full Text] [Related]
7. Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients.
Venclovas Z; Jievaltas M; Milonas D
Front Oncol; 2019; 9():1286. PubMed ID: 31824859
[No Abstract] [Full Text] [Related]
8. [Difference between prostate cancer patients' Gleason scores from preoperative biopsy and those from postoperative pathology].
Zhao XD; Liu YH; Hu J; Wang ZH; Jin XX; Ma MF; Zhou YL; Chen YH; Cao J; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 May; 29(5):393-401. PubMed ID: 38602754
[TBL] [Abstract][Full Text] [Related]
9. Very-high-risk localized prostate cancer: definition and outcomes.
Sundi D; Wang VM; Pierorazio PM; Han M; Bivalacqua TJ; Ball MW; Antonarakis ES; Partin AW; Schaeffer EM; Ross AE
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):57-63. PubMed ID: 24189998
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.
Kim JS; Chung JH; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS
J Yeungnam Med Sci; 2023 Oct; 40(4):412-418. PubMed ID: 37376735
[TBL] [Abstract][Full Text] [Related]
11. Quantified treatment effect at the individual level is more indicative for personalized radical prostatectomy recommendation: implications for prostate cancer treatment using deep learning.
Pan H; Wang J; Shi W; Xu Z; Zhu E
J Cancer Res Clin Oncol; 2024 Feb; 150(2):67. PubMed ID: 38302801
[TBL] [Abstract][Full Text] [Related]
12. Management of Localized Prostate Cancer in Men With Human Immunodeficiency Virus: Analysis of a Large Retrospective Cohort.
Vaziri T; Rao YJ; Whalen M; Bethony J; Thakkar P; Lin J; Goyal S
Clin Genitourin Cancer; 2023 Oct; 21(5):614.e1-614.e8. PubMed ID: 37208248
[TBL] [Abstract][Full Text] [Related]
13. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study.
Murakami Y; Kawahara D; Soyano T; Kozuka T; Takahashi Y; Miyake K; Kashihara K; Kashihara T; Kamima T; Oguchi M; Murakami Y; Yoshioka Y; Nagata Y
Br J Radiol; 2024 Jan; 97(1153):142-149. PubMed ID: 38263831
[TBL] [Abstract][Full Text] [Related]
14. Decipher Score predicts prostate specific antigen persistence after prostatectomy.
Treacy PJ; Falagario UG; Magniez F; Ratnani P; Wajswol E; Martini A; Jambor I; Wiklund P; Bentellis I; Barthe F; Kyprianou N; Durand M; Steffens D; Karunaratne S; Leslie S; Thanigasalam R; Tewari A
Minerva Urol Nephrol; 2023 Oct; 75(5):583-590. PubMed ID: 37728494
[TBL] [Abstract][Full Text] [Related]
15. A study on the impact of marital status on the survival status of prostate cancer patients based on propensity score matching.
Chen Q; Zhu X; Hu Y; Chen Y; Dai R; Li J; Zhuang J; Lin Y; Zeng Y; You L; Zeng Y; Huang Q
Sci Rep; 2024 Mar; 14(1):6162. PubMed ID: 38485743
[TBL] [Abstract][Full Text] [Related]
16. The clinical association between coagulation indexes, platelet-related parameters, and bone metastasis of newly diagnosed prostate cancer.
Yu Z; Yuan M; Chen G
Eur J Med Res; 2023 Dec; 28(1):587. PubMed ID: 38093347
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies.
Kontogiannis S; Markantes G; Stamou M; Tsagkarakis M; Mamali I; Giannitsas K; Perimenis P; Georgopoulos N; Athanasopoulos A
Hormones (Athens); 2023 Dec; ():. PubMed ID: 38127275
[TBL] [Abstract][Full Text] [Related]
18. An integrated radiology-pathology machine learning classifier for outcome prediction following radical prostatectomy: Preliminary findings.
Hiremath A; Corredor G; Li L; Leo P; Magi-Galluzzi C; Elliott R; Purysko A; Shiradkar R; Madabhushi A
Heliyon; 2024 Apr; 10(8):e29602. PubMed ID: 38665576
[TBL] [Abstract][Full Text] [Related]
19. Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial.
Li HZ; Qi X; Gao XS; Li XM; Qin SB; Li XY; Ma MW; Bai Y; Chen JY; Ren XY; Li XY; Wang D
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):697-705. PubMed ID: 37717784
[TBL] [Abstract][Full Text] [Related]
20. Predictive model of positive surgical margins after radical prostatectomy based on Bayesian network analysis.
Wang G; Du H; Meng F; Jia Y; Wang X; Yang X
Front Oncol; 2024; 14():1294396. PubMed ID: 38606110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
